Opus Genetics, Inc. Earnings Per Share, Basic and Diluted
Opus Genetics, Inc. (IRD) reported Earnings Per Share, Basic and Diluted of -$5.28 per share for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-11.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-03-11
- Opus Genetics, Inc. earnings per share, basic and diluted for the quarter ending 2020-12-31 was -$2.93.
- Opus Genetics, Inc. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.33.
- Opus Genetics, Inc. earnings per share, basic and diluted for the quarter ending 2020-06-30 was -$0.62.
- Opus Genetics, Inc. earnings per share, basic and diluted for the quarter ending 2020-03-31 was -$0.15.
- Opus Genetics, Inc. earnings per share, basic and diluted for fiscal 2020 was -$5.28.
- Opus Genetics, Inc. earnings per share, basic and diluted for fiscal 2019 was -$2.17.
- Opus Genetics, Inc. earnings per share, basic and diluted for fiscal 2018 was -$5.25.
- Opus Genetics, Inc. earnings per share, basic and diluted for fiscal 2017 was -$0.92.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2020-12-31 | -$2.93 derived: net income ÷ weighted average shares · filed 2022-03-24 | -$3.76 derived: net income ÷ weighted average shares · filed 2022-03-24 | -$4.42 derived: net income ÷ weighted average shares · filed 2022-03-24 | -$5.28 10-K · filed 2021-03-11 | |||
| 2020-09-30 | -$0.33 10-Q · filed 2020-10-29 | -$0.69 derived: net income ÷ weighted average shares · filed 2021-11-12 | -$1.10 10-Q · filed 2020-10-29 | -$1.81 derived: net income ÷ weighted average shares · filed 2021-11-12 | |||
| 2020-06-30 | -$0.62 10-Q · filed 2020-08-14 | -$0.77 10-Q · filed 2020-08-14 | -$1.62 derived: net income ÷ weighted average shares · filed 2021-11-12 | -$2.08 derived: net income ÷ weighted average shares · filed 2021-11-12 | |||
| 2020-03-31 | -$0.15 10-Q · filed 2020-05-07 | -$1.39 derived: net income ÷ weighted average shares · filed 2021-11-12 | -$1.76 derived: net income ÷ weighted average shares · filed 2021-11-12 | -$2.38 derived: net income ÷ weighted average shares · filed 2021-11-12 | |||
| 2019-12-31 | -$1.35 derived: net income ÷ weighted average shares · filed 2021-03-11 | -$0.76 derived: net income ÷ weighted average shares · filed 2021-03-11 | -$1.51 derived: net income ÷ weighted average shares · filed 2021-03-11 | -$2.17 10-K · filed 2021-03-11 | -$2.18 10-K · filed 2020-02-21 | ||
| 2019-09-30 | -$0.49 10-Q · filed 2020-10-29 | -$1.10 derived: net income ÷ weighted average shares · filed 2020-10-29 | -$1.72 10-Q · filed 2020-10-29 | -$2.66 derived: net income ÷ weighted average shares · filed 2020-10-29 | |||
| 2019-06-30 | -$0.61 10-Q · filed 2020-08-14 | -$1.23 10-Q · filed 2020-08-14 | -$2.19 derived: net income ÷ weighted average shares · filed 2020-08-14 | -$3.94 derived: net income ÷ weighted average shares · filed 2020-08-14 | |||
| 2019-03-31 | -$0.62 10-Q · filed 2020-05-07 | -$1.60 derived: net income ÷ weighted average shares · filed 2020-05-07 | -$3.43 derived: net income ÷ weighted average shares · filed 2020-05-07 | -$4.84 derived: net income ÷ weighted average shares · filed 2020-05-07 | |||
| 2018-12-31 | -$0.09 10-K · filed 2019-03-07 | -$2.98 derived: net income ÷ weighted average shares · filed 2020-02-21 | -$4.44 derived: net income ÷ weighted average shares · filed 2020-02-21 | -$5.25 10-K · filed 2020-02-21 | -$0.44 10-K · filed 2019-03-07 | ||
| 2018-09-30 | -$2.02 10-Q · filed 2019-11-06 | -$0.17 10-Q · filed 2018-11-02 | -$3.47 derived: net income ÷ weighted average shares · filed 2019-11-06 | -$4.26 10-Q · filed 2019-11-06 | -$0.35 10-Q · filed 2018-11-02 | -$1.52 derived: net income ÷ weighted average shares · filed 2019-11-06 | |
| 2018-06-30 | -$1.45 10-Q · filed 2019-08-07 | -$0.12 10-K · filed 2019-03-07 | -$2.24 10-Q · filed 2019-08-07 | -$0.78 derived: net income ÷ weighted average shares · filed 2019-08-07 | -$0.65 derived: net income ÷ weighted average shares · filed 2019-08-07 | ||
| 2018-03-31 | -$0.79 10-Q · filed 2019-05-10 | -$0.07 10-Q · filed 2018-05-04 | -$0.33 derived: net income ÷ weighted average shares · filed 2019-05-10 | -$0.32 derived: net income ÷ weighted average shares · filed 2019-05-10 | |||
| 2017-12-31 | -$0.12 derived: net income ÷ weighted average shares · filed 2019-03-07 | -$0.16 derived: net income ÷ weighted average shares · filed 2019-03-07 | -$0.92 10-K · filed 2019-03-07 | ||||
| 2017-09-30 | -$0.04 10-Q · filed 2018-11-02 | -$0.83 10-Q · filed 2018-11-02 | |||||
| 2017-03-31 | -$0.91 10-Q · filed 2018-05-04 | -$0.09 10-Q · filed 2017-05-03 | -$0.93 derived: net income ÷ weighted average shares · filed 2019-03-07 | -$1.08 derived: net income ÷ weighted average shares · filed 2019-03-07 | -$0.38 derived: net income ÷ weighted average shares · filed 2019-03-07 | ||
| 2016-12-31 | -$0.02 10-K · filed 2018-03-09 | $0.00 10-K · filed 2017-02-24 | -$0.15 derived: net income ÷ weighted average shares · filed 2018-03-09 | -$0.06 derived: net income ÷ weighted average shares · filed 2018-03-09 | -$0.43 10-K · filed 2018-03-09 | -$0.04 10-K · filed 2017-02-24 | |
| 2016-09-30 | -$0.13 10-K · filed 2018-03-09 | -$0.01 10-Q · filed 2016-11-04 | -$0.04 derived: net income ÷ weighted average shares · filed 2018-03-09 | -$0.42 10-Q · filed 2017-11-03 | -$0.04 10-Q · filed 2016-11-04 | $1.59 derived: net income ÷ weighted average shares · filed 2018-03-09 | |
| 2016-06-30 | -$0.08 10-K · filed 2018-03-09 | -$0.01 10-Q · filed 2016-08-05 | -$0.03 10-Q · filed 2016-08-05 | $0.52 derived: net income ÷ weighted average shares · filed 2018-03-09 | -$0.39 derived: net income ÷ weighted average shares · filed 2018-03-09 | ||
| 2016-03-31 | -$0.20 10-K · filed 2018-03-09 | -$0.02 10-Q · filed 2016-05-06 | $0.05 derived: net income ÷ weighted average shares · filed 2018-03-09 | $0.40 derived: net income ÷ weighted average shares · filed 2018-03-09 | -$0.59 derived: net income ÷ weighted average shares · filed 2018-03-09 | ||
| 2015-12-31 | -$0.02 10-K · filed 2017-02-24 | $0.05 derived: net income ÷ weighted average shares · filed 2018-03-09 | $0.29 derived: net income ÷ weighted average shares · filed 2018-03-09 | -$0.79 10-K · filed 2018-03-09 | -$0.08 10-K · filed 2016-03-14 | ||
| 2015-09-30 | -$0.02 10-K · filed 2017-02-24 | -$0.04 derived: net income ÷ weighted average shares · filed 2017-02-24 | -$0.06 10-Q · filed 2016-11-04 | -$0.08 derived: net income ÷ weighted average shares · filed 2017-02-24 | |||
| 2015-06-30 | -$0.02 10-K · filed 2017-02-24 | -$0.04 10-Q · filed 2016-08-05 | -$0.05 derived: net income ÷ weighted average shares · filed 2017-02-24 | -$0.06 derived: net income ÷ weighted average shares · filed 2017-02-24 | |||
| 2015-03-31 | -$0.02 10-K · filed 2017-02-24 | -$0.04 derived: net income ÷ weighted average shares · filed 2017-02-24 | -$0.05 derived: net income ÷ weighted average shares · filed 2017-02-24 | -$0.05 derived: net income ÷ weighted average shares · filed 2017-02-24 | |||
| 2014-12-31 | -$0.01 10-K · filed 2016-03-14 | -$0.02 derived: net income ÷ weighted average shares · filed 2017-02-24 | -$0.02 derived: net income ÷ weighted average shares · filed 2017-02-24 | -$0.11 10-K · filed 2017-02-24 | |||
| 2014-09-30 | -$0.01 10-K · filed 2016-03-14 | -$0.01 derived: net income ÷ weighted average shares · filed 2016-03-14 | -$0.09 10-Q · filed 2015-11-02 | -$0.11 derived: net income ÷ weighted average shares · filed 2016-03-14 | |||
| 2014-06-30 | $0.00 10-K · filed 2016-03-14 | -$0.08 10-Q · filed 2015-08-07 | -$0.10 derived: net income ÷ weighted average shares · filed 2016-03-14 | -$0.12 derived: net income ÷ weighted average shares · filed 2016-03-14 | |||
| 2014-03-31 | -$0.09 10-K · filed 2016-03-14 | -$0.11 derived: net income ÷ weighted average shares · filed 2016-03-14 | -$0.13 derived: net income ÷ weighted average shares · filed 2016-03-14 | -$0.16 derived: net income ÷ weighted average shares · filed 2016-03-14 | |||
| 2013-12-31 | -$0.02 derived: net income ÷ weighted average shares · filed 2016-03-14 | -$0.04 derived: net income ÷ weighted average shares · filed 2016-03-14 | -$0.06 derived: net income ÷ weighted average shares · filed 2016-03-14 | -$0.07 10-K · filed 2016-03-14 | |||
| 2013-09-30 | -$0.02 10-Q · filed 2014-11-12 | -$0.04 derived: net income ÷ weighted average shares · filed 2014-11-12 | -$0.06 10-Q · filed 2014-11-12 | -$0.06 derived: net income ÷ weighted average shares · filed 2014-11-12 | |||
| 2013-06-30 | -$0.03 10-Q · filed 2014-08-13 | -$0.04 10-Q · filed 2014-08-13 | -$0.04 derived: net income ÷ weighted average shares · filed 2014-08-13 | -$0.07 derived: net income ÷ weighted average shares · filed 2014-08-13 | |||
| 2013-03-31 | -$0.01 10-Q · filed 2014-05-14 | -$0.01 derived: net income ÷ weighted average shares · filed 2014-05-14 | -$0.04 derived: net income ÷ weighted average shares · filed 2014-05-14 | -$0.05 derived: net income ÷ weighted average shares · filed 2014-05-14 | |||
| 2012-12-31 | -$0.00 derived: net income ÷ weighted average shares · filed 2014-03-21 | -$0.03 derived: net income ÷ weighted average shares · filed 2014-03-21 | -$0.04 derived: net income ÷ weighted average shares · filed 2014-03-21 | -$0.06 10-K · filed 2014-03-21 | |||
| 2012-09-30 | -$0.03 10-Q · filed 2013-11-13 | -$0.04 derived: net income ÷ weighted average shares · filed 2013-11-13 | -$0.06 10-Q · filed 2013-11-13 | -$0.06 derived: net income ÷ weighted average shares · filed 2014-03-21 | |||
| 2012-06-30 | -$0.01 10-Q · filed 2013-08-12 | -$0.03 10-Q · filed 2013-08-12 | -$0.03 derived: net income ÷ weighted average shares · filed 2014-03-21 | -$0.04 derived: net income ÷ weighted average shares · filed 2014-03-21 | |||
| 2012-03-31 | -$0.02 10-Q · filed 2013-05-09 | -$0.02 derived: net income ÷ weighted average shares · filed 2014-03-21 | -$0.03 derived: net income ÷ weighted average shares · filed 2014-03-21 | -$0.09 derived: net income ÷ weighted average shares · filed 2014-03-21 | |||
| 2011-12-31 | $0.00 derived: net income ÷ weighted average shares · filed 2014-03-21 | -$0.01 derived: net income ÷ weighted average shares · filed 2014-03-21 | -$0.07 derived: net income ÷ weighted average shares · filed 2014-03-21 | -$0.12 10-K · filed 2013-03-22 | |||
| 2011-09-30 | -$0.02 10-Q · filed 2012-11-08 | -$0.08 derived: net income ÷ weighted average shares · filed 2012-11-08 | -$0.13 10-Q · filed 2012-11-08 | ||||
| 2011-06-30 | -$0.06 10-Q · filed 2012-08-08 | -$0.11 10-Q · filed 2012-08-08 | |||||
| 2011-03-31 | -$0.05 10-Q · filed 2012-05-09 | ||||||
| 2010-12-31 | -$0.18 10-K · filed 2012-03-16 | ||||||
| 2010-09-30 | $0.00 10-Q · filed 2011-11-09 | -$0.15 10-Q · filed 2011-11-09 | |||||
| 2010-06-30 | -$0.05 10-Q · filed 2011-08-09 | -$0.16 10-Q · filed 2011-08-09 | |||||
| 2009-12-31 | -$0.05 10-K · filed 2012-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |